No Data
Announcements of individual stocks regarding the personnel transfer of branch managers (PDF 231.36 KB)
List of conversion stocks (Part 2) [List of parabolic signal conversion stocks]
○ List of stocks converted to sell in the market Code Stock Name Closing Price SAR Main Board <1726> Br. HD 343 350 <1898> Seiki Tokyu 15521586 <2127> Japan M&A 656711 <2170> LINK & M 556608 <2209> Imuraya G 23982450 <2326> DigiArts 57906180 <2331> ALSOK 10671136 <2533> Oenon
Nikkei Average Contribution Ranking (closing) - The Nikkei Average rebounded for the first time in four days, with Fast Retailing and Tokyo Electron contributing approximately 86 yen.
As of the close on the 15th, the number of rising and falling stocks in the Nikkei average constituents was 117 gaining stocks, 106 losing stocks, and 2 unchanged. The US stock market fell on the 14th. The dow inc dropped by 207.33 points to 43,750.86, while the nasdaq closed down 123.07 points at 19,107.65. The decline in long-term interest rates was positively received, leading to a slight rise after the opening. However, strong inflation was confirmed in the October Producer Price Index (PPI), and there were also concerns regarding new insurance claims for unemployment.
Terumo has obtained the 'Kurumin Certification' from the Minister of Health, Labour and Welfare as a company supporting child-rearing.
On November 15, 2024, Terumo Corporation (Headquarters: Shibuya-ku, Tokyo, President: Mitsuru Samejima) would like to announce that it has been certified as a "Kurumin" company by the Ministry of Health, Labour and Welfare as a "childcare support company." The "Kurumin Certification" is a proof of recognition as a "childcare support company," approved by the Minister of Health, Labour and Welfare. Companies can receive certification if they achieve the childcare support goals they have set themselves based on the Next Generation Nurturing Support Measures Promotion Act and meet certain criteria. Terumo is
Terumo to start producing new blood and cell technology company products at its factory in Hangzhou, China.
Top November 15, 2024 Terumo Corporation (Headquarters: Shibuya-ku, Tokyo, President: Hikari Samejima) announces that its US subsidiary Terumo BCT, Inc. (hereinafter referred to as Terumo BCT) in Hangzhou, Zhejiang Province, China, will produce Terumo BCT products at the Hangzhou Plant of its Chinese subsidiary. In the future, Terumo BCT will produce the component blood collection device "Trima Accel" at the Hangzhou Plant.
Express News | Blood separation technology giant Terumo BCT has initiated domestic manufacturing: plans to invest 0.1 billion yuan in the Chinese market by 2025.
No Data
No Data